HT
AXSM icon

HAP Trading’s Axsome Therapeutics AXSM Stock Holding History

HAP Trading’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,700
Closed -$6.22K – 735
2024
Q4 		$6.22K Buy
20,700
+1,000
+5% +$92K ﹤0.01% 642
2024
Q3 		$52.2K Buy
+19,700
New +$1.72M 0.03% 467
2022
Q3 		– Sell
-10,400
Closed -$74K – 1811
2022
Q2 		$74K Buy
+10,400
New +$329K 0.01% 959
2021
Q4 		– Sell
-13,600
Closed -$320K – 2613
2021
Q3 		$320K Sell
13,600
-600
-4% -$23.4K 0.02% 837
2021
Q2 		$139K Buy
+14,200
New +$852K 0.01% 1111
2020
Q2 		– Sell
-32,600
Closed -$91K – 1745
2020
Q1 		$91K Buy
+32,600
New +$2.66M 0.01% 680

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return